By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Discovering, developing and commercializing therapies derived from or incorporating genome-editing3.51M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Switzerland3.51M100.00%